Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 718-721

  Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; RECOMBINANT THROMBOMODULIN;

CLINICAL TRIAL; CONFERENCE PAPER; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032696866     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615902     Document Type: Conference Paper

References (26)

1. Maruyama I. Biology of endothelium. Lupus. 1998;(Suppl 2):S41-S43.
2. Broze GJ Jr. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol. 1992;29:159-169.
3. Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost. 1993;70:29-35.
4. Maruyama I, Majerus PW. The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem. 1985;260:15432-15438.
5. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1990:163:740-745.
6. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thromobomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 1989;73:159-165.
7. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahra S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J. 1987;69:1891-1899.
8. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K. The last three consecutive epidermal growth-like structures of human thrombomodulin comprises the minimum functional domains for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem. 1989;264:10351-10353.
9. Gomi K, Zushi M, Honda G, Kawahara S, Matsuzaki O, Kanabayshi Y, Yamamto S, Maruyama I, Suzuki K. Antithrombotic effect of recombinant thrombomodulin on thrombin-induced thromobombolism in mice. Blood. 1990;75:1396-1399.
10. Kumar R, Beguin S, Hemker HC. The influence of fibrinogen and fibrin on thrombin generation-evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost. 1994;72:713-721.
11. Mohri M, Suzuki M, Sugimoto E, Sata M, Yamamoto S, Maruyama I. Effects of recombinant human soluble thrombomodulin(rhs-TM) on clot-induced coagulation in human plasma. Thromb Haemost. 1998;80:925-929.
12. Arimori M, Watanabe N, Ohishi R, Gomi K, Kiyota T, Yamamoto S, Ishida T, Mauyama I. Recombinant soluble human thrombomodulin delivers bounded thrombin to antithrombin III:thrombomodulin associates with free thrombin and is recycled to activate protein C. Thromb Haemost. 1993;70:418-422.
13. Nakashima M, Uematsu T, Umemura K, Maruyama I, Tsuruta K. A novel recombinant soluble human thrombomodulin, ART-123, activates the protein C pathway in healthy volunteers. J Clin Pharmacol. 1998;38:540-544.
14. Gonda Y, Saitoh K, Hirata S, Aoki K, Mohri M, Gomi K, Sugihara T, Kiyota T, Yamamoto S, Ishida T, Maruyama I. Antithrombotic effect of recombinant human soluble thrombomodulin on edotoxin-induced disseminated intravascular coagulation in rats. Thromb Res. 1993;71:325-335.
15. Mohri M, Oka M, Aoki Y, Gonda Y, Hirata S, Gomi K, Kiyota T, Sugihara T, Yamamoto S, Ishida T, Maruyama I. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol. 1994;45:293-303.
16. Mohri M, Gonda Y, Oka M, Aoki Y, Gomi K, Kiyota T, Sugihara T, Yamamoto S, Maruyama I. The antithrombotic effects of recombinant human soluble thrombomodulin(rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys(Macaca fascicularis). Blood Coagul Fibrinolysis. 1997;8:274-283.
17. Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamto S, Ishida T, Maruyama I. Effects of recombinant human soluble thrombomodulin(rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb Haemost. 1994;71:452-455.
18. Nakashima M, Kanamaru M, Umemura K, Tsuruta K. Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123 in healthy male vounteers. J Clin Pharmacol. 1998;38:40-44.
19. Marlar RA, Enders-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with DIC. Blood. 1985;66:59-65.
20. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest.1987;79:917-923.
21. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary injury by inhibiting activated leukocytes in rats. Blood. 1996;87:642-647.
22. Hancock WW, Salem HH. Activated protein C(APC) blocks endotoxin-induced renal injury: reduction in cytokine expression, endothelial activation, fibrin deposition and cellular infiltration. J Am Soc Nephrol. 1993;4:605.
23. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated prtotein C on the responses of human mononuclear phagocytes to LPS, IFN-γ or phorbol ester. J Immunol. 1994;153:3664-3672.
24. Grinnell BW, Hermann RB, Yan SB. Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology. 1994;4:221-225.
25. Connolly AJ, Ishihara H, Kahn ML, Farese RV, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 1996;381:516-519.
26. Nakajima T, Kitajima I, Shin H, Takasaki I, Shigeta K, Abeyama K, Yamashita Y, Tokioka T, Soejima Y, Maruyama I. Involvement of NF-kB activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem Biophys Res Commun. 1994;204:950-955.